Retraction Note to: The ‘obesity paradox’ and survival after colorectal cancer: true or false?

被引：0
|
作者：
Andrew G. Renehan
机构：
[1] University of Manchester,Department of Surgery, Institute of Cancer Sciences
[2] Manchester Academic Health Science Centre,undefined
[3] The Christie NHS Foundation Trust,undefined
来源：
Cancer Causes & Control | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1203 / 1203
相关论文
共 50 条
  • [41] Authors' reply: "The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis"
    Li, Yiding
    Hong, Liu
    NUTRITION REVIEWS, 2023, 81 (02) : 233 - 234
  • [42] Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts
    Lim, Dong Min
    Lee, Hyunsu
    Eom, Kisang
    Kim, Yun Hak
    Kim, Shin
    JOURNAL OF CANCER, 2023, 14 (02): : 379 - 392
  • [43] Obesity and the Importance of Cardiovascular Disease Surveillance After Colorectal Cancer
    Passarelli, Michael N.
    JAMA ONCOLOGY, 2019, 5 (07) : 973 - 974
  • [44] Association Between Colorectal Cancer Susceptibility Loci and Survival Time After Diagnosis With Colorectal Cancer
    Phipps, Amanda I.
    Newcomb, Polly A.
    Garcia-Albeniz, Xabier
    Hutter, Carolyn M.
    White, Emily
    Fuchs, Charles S.
    Hazra, Aditi
    Ogino, Shuji
    Nan, Hongmei
    Ma, Jing
    Campbell, Peter T.
    Figueiredo, Jane C.
    Peters, Ulrike
    Chan, Andrew T.
    GASTROENTEROLOGY, 2012, 143 (01) : 51 - U555
  • [45] Retraction Note to: FOXC2 promotes colorectal cancer metastasis by directly targeting MET
    Y-M Cui
    H-L Jiao
    Y-P Ye
    C-M Chen
    J-X Wang
    N. Tang
    T-T Li
    J. Lin
    L. Qi
    P. Wu
    S-Y Wang
    M-R He
    L. Liang
    X-W Bian
    W-T Liao
    Y-Q Ding
    Oncogene, 2022, 41 : 2529 - 2529
  • [46] Retraction Note to: Identification of profilin 1 as the primary target for the anti-cancer activities of Furowanin A in colorectal cancer
    Pharmacological Reports, 2021, 73 : 317 - 317
  • [47] RETRACTION: Retraction Note: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
    Crociani, Olivia
    Zanieri, Francesca
    Pillozzi, Serena
    Lastraioli, Elena
    Stefanini, Matteo
    Fiore, Antonella
    Fortunato, Angelo
    D'Amico, Massimo
    Masselli, Marika
    De Lorenzo, Emanuele
    Gasparoli, Luca
    Chiu, Martina
    Bussolati, Ovidio
    Becchetti, Andrea
    Arcangeli, Annarosa
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [48] A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage II and III colorectal cancer patients
    Hu, Chunlei
    Zhang, Qi
    Jin, Xinghan
    Zhang, Lin
    Zhang, Yiming
    Zhu, Qiankun
    Tang, Meng
    Lyv, Guoqing
    Shi, Hanping
    CLINICAL NUTRITION, 2021, 40 (04) : 2410 - 2419
  • [49] Survival benefit of obesity in stage IV colorectal cancer: Better tolerability of chemotherapy?
    Tran, Catherine G.
    Hill, Elise E.
    Jensen, Braden
    Stark, Austin C.
    Flannery, Meghan
    Berg, Daniel James
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Obesity and overweight are associated with worse survival in early-onset colorectal cancer
    Aeschbacher, Pauline
    Garoufalia, Zoe
    Dourado, Justin
    Rogers, Peter
    Emile, Sameh Hany
    Matamoros, Eric
    Nagarajan, Arun
    Rosenthal, Raul J.
    Wexner, Steven D.
    SURGERY, 2024, 176 (02) : 295 - 302
12345